HHV8-Negative Effusion-Based Large B Cell Lymphoma Arising in Chronic Myeloid Leukemia Patients under Dasatinib Treatment: A Report of Two Cases

HHV8-Negative Effusion-Based Large B Cell Lymphoma Arising in Chronic Myeloid Leukemia Patients under Dasatinib Treatment: A Report of Two Cases

Tyrosine kinase inhibitors (TKIs) are the treatment of choice for BCR-ABL1-positive chronic myeloid leukemia (CML). Although TKIs have substantially improved prognosis of CML patients, their use is not free of adverse effects. Dasatinib is a second generation TKI frequently associated with pleural e...

Full description

Bibliographic Details
Main Authors: Stefano Fiori, Elisabetta Todisco, Safaa Ramadan, Federica Gigli, Patrizia Falco, Alessandra Iurlo, Cristiano Rampinelli, Giorgio Croci, Stefano A. Pileri, Corrado Tarella
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Biology
Subjects:
CML
TKIs
large B cell lymphoma
EBL
pleural effusion
dasatinib
Online Access:https://www.mdpi.com/2079-7737/10/2/152

Internet

https://www.mdpi.com/2079-7737/10/2/152

Similar Items